Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (581)	7/13/1999 4:20:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4474

Mike: Regarding....... From the Ariad annual report: 'The technologies currently established in the Genomics Center include custom cDNA-based gene chip arrays (Molecular Dynamics), commercial high-density chip arrays (Affymetrix), cDNA library construction, high-throughput EST sequencing, high- throughput FL cloning and sequencing, integrated automation systems, genetic sreen methodologies for gene discovery, mouse gene targeting technologies, and bioinformatics tools for analysis of DNA sequencing and gene chip data.' That's a fancy way of saying "a nice, well-funded lab".